Literature DB >> 13260676

Chlorpromazine, reserpine, and isoniazid treatment in mental disorder; a preliminary communication.

J K HEWAT, P W LEACH, R W SIMPSON.   

Abstract

Entities:  

Keywords:  CHLORPROMAZINE/therapeutic use; MENTAL DISORDERS/therapy; NICOTINIC ACID ISOMERS/therapeutic use; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh：

Substances：

Year:  1955        PMID： 13260676      PMCID： PMC1981333          DOI： 10.1136/bmj.2.4948.1119

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  10 in total

1.  Fatal agranulocytosis during treatment with chlorpromazine.

Authors:  J R TASKER
Journal:  Br Med J       Date:  1955-04-16

2.  [A Rauwolfia alkaloid in psychiatry: similarity of its effects to those of chloropromazine].

Authors:  E WEBER
Journal:  Schweiz Med Wochenschr       Date:  1954-08-21

3.  Chlorpromazine; a major advance in psychiatric treatment.

Authors:  V KINROSS-WRIGHT
Journal:  Postgrad Med       Date:  1954-10       Impact factor: 3.840

4.  An evaluation of chlorpromazine ("largacill") in psychiatry.

Authors:  F B CHARATAN
Journal:  J Ment Sci       Date:  1954-10

5.  Acute pellagra during isoniazid therapy.

Authors:  R B MCCONNELL; H D CHEETHAM
Journal:  Lancet       Date:  1952-11-15       Impact factor: 79.321

6.  Human pharmacology of reserpine.

Authors:  T WINSOR
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

7.  Clinical experience with reserpine (serpasil): a controlled study.

Authors:  H P DUSTAN; R D TAYLOR; A C CORCORAN; I H PAGE
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

8.  The absorption, distribution, excretion, and short-term toxicity of isonicotinic acid hydrazide (nydrazid) in man.

Authors:  D F ELMENDORF; W U CAWTHON; C MUSCHENHEIM; W McDERMOTT
Journal:  Am Rev Tuberc       Date:  1952-04

9.  Pharmacology of isonicotinic acid hydrazide (nydrazid).

Authors:  B RUBIN; G L HASSERT; B G H THOMAS; J C BURKE
Journal:  Am Rev Tuberc       Date:  1952-04

10.  Cardiovascular and renal hemodynamic response to reserpine (serpasil), and clinical results of using this agent for the treatment of hypertension.

Authors:  J H MOYER
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691
  10 in total
  1 in total

1.  Iron poisoning and desferrioxamine.

Authors: 
Journal:  Br Med J       Date:  1966-02-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.